|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Cash provided by operating activities: | |||||
| Net income/(loss) | |||||
| Adjustments to reconcile net income/(loss) to cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Restructuring and other charges | |||||
| Restructuring and other charges/(income) | |||||
| Separation-related (income)/charges | |||||
| Deferred income taxes | |||||
| Pension and other postretirement benefits | |||||
| Share-based compensation | |||||
| Change in investments in trust fund securities | |||||
| Equity in net loss of unconsolidated affiliates | |||||
| Loss on debt extinguishment | |||||
| Other gain | |||||
| Deferred financing fee amortization | |||||
| Loss on asset disposal | |||||
| Other non-cash adjustments | |||||
| Changes in operating assets and liabilities: | |||||
| Trade receivables, net | |||||
| Changes in deferred compensation | |||||
| Inventories | |||||
| Accounts payable, trade and other | |||||
| Contract liability - short-term | |||||
| Contract liability - long-term | |||||
| Income taxes | |||||
| Change in due to related party | |||||
| Change in prepaid and other current assets and other assets | |||||
| Change in accrued and other current and long-term liabilities | |||||
| Cash provided by operating activities | |||||
| Cash used in investing activities: | |||||
| Additions to property, plant and equipment | |||||
| Investments in Livent NQSP securities | |||||
| Proceeds from settlement of long-term supply agreement | |||||
| Investments in unconsolidated affiliates | |||||
| Other investing activities | |||||
| Cash used in investing activities | |||||
| Cash (used in)/provided by financing activities: | |||||
| Proceeds from Revolving Credit Facility | |||||
| Repayments of Revolving Credit Facility | |||||
| Proceeds from 2025 Notes | |||||
| Payments of financing fees | |||||
| Proceeds from issuance of common stock - incentive plans | |||||
| Proceeds from IPO, net of fees | |||||
| Distribution payment to FMC | |||||
| Net change in net parent investment | |||||
| Repayment of QLP Note | |||||
| Proceeds from Offering | |||||
| Net purchases of treasury stock - Livent NQSP | |||||
| Cash (used in)/provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Increase/(decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure for cash flow: | |||||
| Cash payments for income taxes, net of refunds | |||||
| Cash payments for interest | |||||
| Cash payments for Restructuring and other charges | |||||
| Cash (receipts)/payments for Separation-related charges | |||||
| Accrued capital expenditures | |||||
| Accrued investment in unconsolidated affiliates | |||||
| Non-cash assumption of QLP Note | |||||
| Non-cash investment in unconsolidated affiliate | |||||
| Operating lease right-of-use assets and lease liabilities recorded for ASC 842 | |||||
Loading...